Income Statement for VVOS

	Vivos Therapeutics, Inc. (VVOS)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31											2021-Mar-31	2020-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023											Q1-FY2021	Q4-FY2020
Total Revenue		6,783,000$	3,820,000$	3,016,000$	3,698,000$	3,860,000$	4,054,000$	3,419,000$	3,248,000$	3,301,000$	3,395,000$	3,857,000$								3,447,881$				3,196,507$
QoQ%		77.57%	26.66%	(18.44%)	(4.20%)	(4.79%)	18.57%	5.27%	(1.61%)	(2.77%)	(11.98%)
YoY%		75.73%	(5.77%)	(11.79%)	13.86%	16.93%	19.41%	(11.36%)												7.86%
Cost Of Revenue		2,846,000$	1,710,000$	1,507,000$	1,601,000$	1,526,000$	1,403,000$	1,482,000$	1,159,000$	1,554,000$	1,297,000$	1,520,000$								757,996$				780,456$
Gross Profit		3,937,000$	2,110,000$	1,509,000$	2,097,000$	2,334,000$	2,651,000$	1,937,000$	2,089,000$	1,747,000$	2,098,000$	2,337,000$								2,689,885$				2,416,051$
Gross Margin		58.04%	55.24%	50.03%	56.71%	60.47%	65.39%	56.65%	64.32%	52.92%	61.80%	60.59%								78.02%				75.58%
Operating Expenses		8,671,000$	6,975,000$	5,427,000$	4,903,000$	4,979,000$	4,587,000$	5,722,000$	6,222,000$	5,387,000$	6,615,000$	7,342,000$								6,096,790$				4,973,775$
Operating Income		(4,734,000$)	(4,865,000$)	(3,918,000$)	(2,806,000$)	(2,645,000$)	(1,936,000$)	(3,785,000$)	(4,133,000$)	(3,640,000$)	(4,517,000$)	(5,005,000$)								(3,406,905$)				(2,557,724$)
Operating Margin		(69.79%)	(127.36%)	(129.91%)	(75.88%)	(68.52%)	(47.76%)	(110.71%)	(127.25%)	(110.27%)	(133.05%)	(129.76%)								(98.81%)				(80.02%)
Interest Income																				7,745$				20,880$
Interest Expenses		500,000$																		82$				43,723$
Income Before Tax		(5,400,000$)	(5,013,000$)	(3,864,000$)	(2,827,000$)	(2,616,000$)	(1,930,000$)	(3,763,000$)	(4,259,000$)	(2,093,000$)	(5,528,000$)	(1,703,000$)								(3,399,242$)				(2,580,567$)
Tax Expenses
Net Income		(5,400,000$)	(5,013,000$)	(3,864,000$)	(2,827,000$)	(2,616,000$)	(1,930,000$)	(3,763,000$)	(4,259,000$)	(2,093,000$)	(5,528,000$)	(1,703,000$)								(3,399,242$)				(2,580,567$)
Profit Margin		(79.61%)	(131.23%)	(128.12%)	(76.45%)	(67.77%)	(47.61%)	(110.06%)	(131.13%)	(63.41%)	(162.83%)	(44.15%)								(98.59%)				(80.73%)
TTM		(98.77%)	(99.49%)	(76.82%)	(74.09%)	(86.19%)	(85.90%)	(117.06%)	(98.42%)
Earnings to Minority																								250,000$
Earnings to Common Shareholders		(5,400,000$)	(5,013,000$)	(3,864,000$)	(2,827,000$)	(2,616,000$)	(1,930,000$)	(3,763,000$)	(4,259,000$)	(2,093,000$)	(5,528,000$)	(1,703,000$)								(3,399,242$)				(2,830,567$)
QoQ%		(7.72%)	(29.74%)	(36.68%)	(8.07%)	(35.54%)	48.71%	11.65%	(103.49%)	62.14%	(224.60%)
YoY%		(106.42%)	(159.74%)	(2.68%)	33.62%	(24.99%)	65.09%	(120.96%)												(20.09%)
Earnings Per Share, Basic		(0.49$)	(0.55$)	(0.45$)	(0.36$)	(0.40$)	(0.60$)	(1.63$)	(2.85$)	(1.75$)	(4.62$)	(1.72$)								(0.19$)				(0.23$)
Earnings Per Share, Diluted		(0.49$)	(0.55$)	(0.45$)	(0.36$)	(0.40$)	(0.60$)	(1.63$)	(2.85$)	(1.75$)	(4.62$)	(1.72$)								(0.19$)				(0.23$)
Unlevered FCF Per Share, Basic		(0.37$)	(0.47$)	(0.46$)	(0.39$)	(0.66$)	(0.96$)	(1.16$)	(1.95$)	(2.47$)	(2.59$)	(3.81$)								(0.23$)				(0.04$)
Unlevered FCF Per Share, Diluted		(0.37$)	(0.47$)	(0.46$)	(0.39$)	(0.66$)	(0.96$)	(1.16$)	(1.95$)	(2.47$)	(2.59$)	(3.81$)								(0.23$)				(0.04$)
Average Shares, Basic		10,963,590	9,087,202	8,595,288	7,927,707	6,615,320	3,228,363	2,308,154	1,492,339	1,197,258	1,197,258	990,669								18,210,548				12,471,955
Average Shares, Diluted		10,963,590	9,087,202	8,595,288	7,927,707	6,615,320	3,228,363	2,308,154	1,492,339	1,197,258	1,197,258	990,669								18,210,548				12,471,955
EBIT		(4,900,000$)	(5,013,000$)	(3,864,000$)	(2,827,000$)	(2,616,000$)	(1,930,000$)	(3,763,000$)	(4,259,000$)	(2,093,000$)	(5,528,000$)	(1,703,000$)								(3,399,160$)				(2,536,844$)
EBITDA		(4,516,000$)	(4,707,000$)	(3,687,000$)	(2,683,000$)	(2,470,000$)	(1,785,000$)	(3,617,000$)	(4,110,000$)	(1,944,000$)	(5,380,000$)	(1,528,000$)								(3,221,663$)				(2,355,876$)